Member Info for apps

First thing says it all.

MMs don’t have stock and they don’t want day traders jumping onboard.

Someone more important is trying to buy up stock and this is the order they want to fill, they don’t want day traders driving the price up and messing with the bigger picture.

1 share @ 0.253 to show -8.36% on the day!

NFX finished with a 1-share Uncrossing Trade at 0.252 despite strong buying at 0.357–0.36 throughout the afternoon. This isn’t typical for this stock and looks suspiciously like someone marking the close lower.

Hoping holders not watching the days trading see the deadline closing price and set an order up out of hours to execute first thing tomorrow.

Very dodgy and looks like MMs are desperate to stock.

Not enough sellers on the way down from 0.5

Too many buyers.

Share price will get battered but I will be buying the dip.

Sounds like EMA asked for the same clarification before granting European ODD.

For me this has ODD approval written all over it but will take a bit longer.

Licensing partner will also be ready to announce, subject to ODD approval. They’ve had plenty of time to get this in place.

Bought ALRT at .64 on a similar hunch.

Sold most a few weeks later at 4p

The 13% stake in Alludium is already worth £13m on speculation alone and current mcap £7.8m, soooo, current fair value 1p.

Depending on news out of Lisbon on Thursday many multiples of 1p is likely.

I like the idea of A2A hub and their will be copycats but there’s so much money sloshing around the bigger firms at the moment, it’s easier to hoover up Alludium than start from scratch and £130m is peanuts to get your hands on the first out the blocks. £1bn seems to be the minimum to fend off the competition at the moment for these AI mammoths.

But have some knowledge having started looking into employing someone to work with n8n for my business.

alludium came on my radar Friday for obvious reasons so done some digging.

Looks exciting, the A2A hub is a complementary technology that addresses a different need to n8n, enabling specialised AI agents to interact with each other in a structured way. An n8n workflow can act as a client within this A2A framework, allowing n8n to leverage the multi-agent orchestration capabilities of A2A.

If this works, the take up for A2A across AI Agent workflow tools is massive as long as they’re speaking to the right people in the space.

Order in for first thing Monday and look forward to their presentation Thursday.

2m dummy sell over bid, no NT

I was concerned this may be fundraise or warrants being unloaded but MMs don't normally take back large quantities of shares over bid without NT when this is happening. So looks like genuine interest!

This is not about good or bad assay results. Either way There is a massive spike coming on the run up to reverse split.

I've traded such on NASDAQ and LSE and this is the MO

It will be harder for them to raise funds through the usual manipulated hype, post split when SP is £1, this will be there last chance for a while to bank big money for drilling.

Position yourselves now in anticipation of fireworks. This is how a fundraise is done, you just have to know when to buy and hold in advance of the pre split re-rate.

This is as close to being an insider as you will get.

Many see a share consolidation and instantly think dilution or bad news ahead — but experienced investors know this pattern well. consolidation often comes just before a major announcement or strategic move, and history shows it can be a precursor to huge spikes.

Smallcaps use this same route to clear the decks, strengthen perception, and then follow up with transformational news, sometimes followed by a placing after the share price has spiked on the news.

The EGM vote should pass smoothly, and those who step in during the consolidation dip frequently find themselves in a perfect position to multibag when the announcement lands. You just have to know that today is the time to be loading up rather than get caught up with the hype on assay results.

Right now, WSBN’s current share price weakness looks far more like an opportunity than a setback. The company is clearly preparing for the next phase, and those with patience and perspective usually reap the rewards.

Sometimes the biggest gains come when sentiment is at its lowest.

Still here, busy day away from screen today

Definitely Wishbones rig. COS002 👍

You can sell your shares and still receive your open offer shares.

Record Date for the Open Offer Was 24th Oct.

Biotech inherently leaky

Can sell 8m, no NT at full bid

You'd think after a 30% daily rise, I would struggle to sell £38k worth into close.

Our buyer will take the lot

News off ODD being granted will not send this parabolic.

When the SP was .2-.3 range, yes, a jump to these levels was expected but here we are, ODD pretty much priced in.

It the news on partnership is what sending it past 3p, I suspect this partnership may be ready for signing on condition they get ODD and will only be announced on ODD being granted.

If the two come together then yes, parabolic.

Maybe that's why we have an X,XXX,XXX buyer constantly picking up stock?!

There are some massive orders to be filled if MMs will take 5m @.4905 without NT when only one MM on bid with 2m

a smallcap would normally start drifting after lunch after such a gain.

As I type, SCAP is on the move up

Looks like those with big bucks see 1p as the loading zone

100% a buy

03-Nov-25 12:12:55 1.00 1,500,000 Unknown* 15.00k

Coming off ASK during auction, very telling. The x,xxx,xxx buyer is still taking what they can.

I still feel 0.85p (£17m mcap) is a more realistic price even before partner announcement if ODD granted.

From there, anywhere between £50m-£100m (2.5p - 5.0p) depending on the quality and terms of the partnership.

MMs happy to take 6m at .4533 (£27,198) without NT.

There's no stock for MM's to trade with, even at these levels sellers are scarce. Maybe MM's will try a hitting a few stop losses with a short sharp drop.

looking at the crazy 9% spread they are trying to stop day traders buying into the rise.

I presume this mornings late buy prints are investors buying in anticipation of the news coming within the expected 90 days (11th Nov) or a partner is on-board and those privvy to such information are carefully buying in. Always a bit of a conspiracy when suggested but half the time, it proves right.

Previous high market cap, around £17m

Currently sitting at approx £7.5m

Would need approx .85p to come close to previous highs.

£17m mcap would be a realistic with FDA ODD, could be many multiples of this with the right announcement on partner.